Latest Breaking News On - From mogrifyoct - Page 1 : comparemela.com

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

United kingdomTadayoshi hirataJonathan milnerDarrinm disleyMogrify limitedAbcam plcAstellas pharma incTrend investment groupFrom mogrifyoctAstellas venture managementParkwalk advisorsAhren innovation capitalAstellas pharmaSenior investment managerAstellas ventureHearing loss